Authors
Elyse R Park, JoRean D Sicks, Brett M Goshe, Ilana F Gareen, Benjamin A Herman, Alexander Taurone, Seth Bittig, Angela Wangari Walter, Susan Regan, Rachel Rosen, Natalie Durieux, Autumn W Rasmussen, Douglas E Levy, Gabriella Nicolosi, Alona Muzikansky, Michael A Thompson, Michelle Lui, Laura Malloy, Irina Gonzalez, Lucy Finkelstein-Fox, Nathan D Munson, Molly M Greenwade, David M King, Bharat Jenigiri, Brian L Burnette, Alyssa D Throckmorton, Martha S Tingen, Ruth C Carlos, Lynne I Wagner, Jamie S Ostroff
Published in
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Pages JCO2502267. Jul 13, 2026. Epub Jul 13, 2026.
Abstract
Persistent smoking among patients diagnosed with cancer is associated with adverse clinical outcomes, yet tobacco treatment has not been integrated into community oncology settings. We conducted a trial of a virtual sustained tobacco treatment intervention across community oncology settings nationwide.
This randomized controlled trial compared the effectiveness of sustained telehealth counseling plus medication (virtual sustained treatment [VST]) to referral to the National Cancer Institute (NCI) quitline (enhanced usual care [EUC]) in assisting patients recently diagnosed with cancer to quit smoking. The VST group received up to 11 synchronous telehealth sessions (four weekly, four biweekly, three monthly) of motivational counseling and up to 12 weeks of free nicotine replacement therapy (NRT).
From August 2019 to December 2022, 306 English- and Spanish-speaking patients were randomly assigned from 37 NCI Community Oncology Research Program community sites. Participants were 70.9% female; 86.3% was White; the median age was 57 years; and 45.4% had non-smoking-related tumors. A total of 221 of 302 (73.2%) smoked within 30 minutes of waking. Six-month, 7-day point abstinence rates were 28.4% (42 of 148) in the VST group versus 14.7% (21 of 143) in the EUC group; there were no significant treatment moderators. A total of 80.8% (126 of 156) of VST participants engaged in counseling, and 85.7% (108 of 126) were dispensed NRT. Participants who completed >8 sessions versus <5 sessions were more likely to quit; P = .005. VST participants were almost four times more likely to report guideline-concordant smoking cessation medication use. Continuous abstinence and significant reduction rates at 6 months were higher in the VST group. The incremental cost per quit was $7,724 in US dollars.
Among recently diagnosed patients, sustained remotely delivered telehealth counseling and free NRT were well utilized and nearly doubled 6-month quit rates compared with EUC. Findings support the benefit of adopting sustained tobacco treatment within community oncology care settings nationwide.
PMID:
42441935
Bibliographic data and abstract were imported from PubMed on 14 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 11
- Comments 0